Dolphin
Senior Member (Voting Rights)
Free fulltext:
https://www.mdpi.com/1660-4601/20/4/3477
Non-Pharmacological Therapies for Post-Viral Syndromes, Including Long COVID: A Systematic Review
by
by Joht Singh Chandan 1,*,Kirsty R. Brown 1,2,Nikita Simms-Williams 1,Nasir Z. Bashir 3,Jenny Camaradou 4,Dominic Heining 5,Grace M. Turner 1,6,Samantha Cruz Rivera 1,6,7,Richard Hotham 1,Sonica Minhas 1,Krishnarajah Nirantharakumar 1,8,Manoj Sivan 9,Kamlesh Khunti 10,Devan Raindi 11,Steven Marwaha 12,Sarah E. Hughes 1,6,7,13,Christel McMullan 1,6,Tom Marshall 1,Melanie J. Calvert 1,6,7,13,14,15,Shamil Haroon 1,† and
Olalekan Lee Aiyegbusi
1,6,7,13,† on behalf of the TLC Study
1
Institute of Applied Health Research, University of Birmingham, Birmingham B15 2TT, UK
2
School of Sport, Exercise and Rehabilitation Sciences, University of Birmingham, Birmingham B15 2TT, UK
3
School of Oral and Dental Sciences, University of Bristol, Bristol BS8 1TH, UK
4
School of Health Sciences, University of East Anglia, Norwich NR4 7TJ, UK
5
Department of Microbiology, Royal Wolverhampton NHS Trust, Wolverhampton WV10 0QP, UK
6
Centre for Patient Reported Outcomes Research, Institute of Applied Health Research, University of Birmingham, Birmingham B15 2TT, UK
7
Birmingham Health Partners Centre for Regulatory Science and Innovation, University of Birmingham, Birmingham B15 2TT, UK
8
Midlands Health Data Research UK, Birmingham B15 2TT, UK
9
School of Medicine, University of Leeds, Leeds LS2 9JT, UK
10
Diabetes Research Centre, University of Leicester, Leicester LE1 7RH, UK
add Show full affiliation list
*
Author to whom correspondence should be addressed.
†
Joint senior author.
Int. J. Environ. Res. Public Health 2023, 20(4), 3477; https://doi.org/10.3390/ijerph20043477
Received: 10 January 2023 / Revised: 11 February 2023 / Accepted: 13 February 2023 / Published: 16 February 2023
(This article belongs to the Special Issue Post-COVID-19 Syndrome or Long COVID: Pathophysiology, Treatments, and Outcomes)
Abstract
Background:
Post-viral syndromes (PVS), including Long COVID, are symptoms sustained from weeks to years following an acute viral infection.
Non-pharmacological treatments for these symptoms are poorly understood.
This review summarises the evidence for the effectiveness of non-pharmacological treatments for PVS.
Methods:
We conducted a systematic review to evaluate the effectiveness of non-pharmacological interventions for PVS, as compared to either standard care, alternative non-pharmacological therapy, or placebo.
The outcomes of interest were changes in symptoms, exercise capacity, quality of life (including mental health and wellbeing), and work capability.
We searched five databases (Embase, MEDLINE, PsycINFO, CINAHL, MedRxiv) for randomised controlled trials (RCTs) published between 1 January 2001 to 29 October 2021.
The relevant outcome data were extracted, the study quality was appraised using the Cochrane risk-of-bias tool, and the findings were synthesised narratively.
Findings:
Overall, five studies of five different interventions (Pilates, music therapy, telerehabilitation, resistance exercise, neuromodulation) met the inclusion criteria.
Aside from music-based intervention, all other selected interventions demonstrated some support in the management of PVS in some patients.
Interpretation:
In this study, we observed a lack of robust evidence evaluating the non-pharmacological treatments for PVS, including Long COVID.
Considering the prevalence of prolonged symptoms following acute viral infections, there is an urgent need for clinical trials evaluating the effectiveness and cost-effectiveness of non-pharmacological treatments for patients with PVS.
Registration:
The study protocol was registered with PROSPERO [CRD42021282074] in October 2021 and published in BMJ Open in 2022.
Keywords:
post-viral syndromes; PVS; COVID-19; Long COVID; post-COVID-19 condition; post-acute sequelae of SARS-CoV-2 infection (PASC); rehabilitation; systematic review; non-pharmacological intervention
https://www.mdpi.com/1660-4601/20/4/3477
Non-Pharmacological Therapies for Post-Viral Syndromes, Including Long COVID: A Systematic Review
by
by Joht Singh Chandan 1,*,Kirsty R. Brown 1,2,Nikita Simms-Williams 1,Nasir Z. Bashir 3,Jenny Camaradou 4,Dominic Heining 5,Grace M. Turner 1,6,Samantha Cruz Rivera 1,6,7,Richard Hotham 1,Sonica Minhas 1,Krishnarajah Nirantharakumar 1,8,Manoj Sivan 9,Kamlesh Khunti 10,Devan Raindi 11,Steven Marwaha 12,Sarah E. Hughes 1,6,7,13,Christel McMullan 1,6,Tom Marshall 1,Melanie J. Calvert 1,6,7,13,14,15,Shamil Haroon 1,† and
Olalekan Lee Aiyegbusi
1,6,7,13,† on behalf of the TLC Study
1
Institute of Applied Health Research, University of Birmingham, Birmingham B15 2TT, UK
2
School of Sport, Exercise and Rehabilitation Sciences, University of Birmingham, Birmingham B15 2TT, UK
3
School of Oral and Dental Sciences, University of Bristol, Bristol BS8 1TH, UK
4
School of Health Sciences, University of East Anglia, Norwich NR4 7TJ, UK
5
Department of Microbiology, Royal Wolverhampton NHS Trust, Wolverhampton WV10 0QP, UK
6
Centre for Patient Reported Outcomes Research, Institute of Applied Health Research, University of Birmingham, Birmingham B15 2TT, UK
7
Birmingham Health Partners Centre for Regulatory Science and Innovation, University of Birmingham, Birmingham B15 2TT, UK
8
Midlands Health Data Research UK, Birmingham B15 2TT, UK
9
School of Medicine, University of Leeds, Leeds LS2 9JT, UK
10
Diabetes Research Centre, University of Leicester, Leicester LE1 7RH, UK
add Show full affiliation list
*
Author to whom correspondence should be addressed.
†
Joint senior author.
Int. J. Environ. Res. Public Health 2023, 20(4), 3477; https://doi.org/10.3390/ijerph20043477
Received: 10 January 2023 / Revised: 11 February 2023 / Accepted: 13 February 2023 / Published: 16 February 2023
(This article belongs to the Special Issue Post-COVID-19 Syndrome or Long COVID: Pathophysiology, Treatments, and Outcomes)
Abstract
Background:
Post-viral syndromes (PVS), including Long COVID, are symptoms sustained from weeks to years following an acute viral infection.
Non-pharmacological treatments for these symptoms are poorly understood.
This review summarises the evidence for the effectiveness of non-pharmacological treatments for PVS.
Methods:
We conducted a systematic review to evaluate the effectiveness of non-pharmacological interventions for PVS, as compared to either standard care, alternative non-pharmacological therapy, or placebo.
The outcomes of interest were changes in symptoms, exercise capacity, quality of life (including mental health and wellbeing), and work capability.
We searched five databases (Embase, MEDLINE, PsycINFO, CINAHL, MedRxiv) for randomised controlled trials (RCTs) published between 1 January 2001 to 29 October 2021.
The relevant outcome data were extracted, the study quality was appraised using the Cochrane risk-of-bias tool, and the findings were synthesised narratively.
Findings:
Overall, five studies of five different interventions (Pilates, music therapy, telerehabilitation, resistance exercise, neuromodulation) met the inclusion criteria.
Aside from music-based intervention, all other selected interventions demonstrated some support in the management of PVS in some patients.
Interpretation:
In this study, we observed a lack of robust evidence evaluating the non-pharmacological treatments for PVS, including Long COVID.
Considering the prevalence of prolonged symptoms following acute viral infections, there is an urgent need for clinical trials evaluating the effectiveness and cost-effectiveness of non-pharmacological treatments for patients with PVS.
Registration:
The study protocol was registered with PROSPERO [CRD42021282074] in October 2021 and published in BMJ Open in 2022.
Keywords:
post-viral syndromes; PVS; COVID-19; Long COVID; post-COVID-19 condition; post-acute sequelae of SARS-CoV-2 infection (PASC); rehabilitation; systematic review; non-pharmacological intervention